It has been shown that patients with stents who receive dual therapy and are taken to non-cardiac surgery without withdrawing the therapy during the preoperative period are at a higher risk of bleeding when compared to patients receiving only aspirin as anti-aggregation therapy 30.
Según se ha demostrado, pacientes con stents implantados que reciben terapia dual y son llevados a cirugía no cardiaca, sin suspender esta en el preoperatorio, tienen un mayor riesgo de sangrado, comparados con la terapia de antiagregación con aspirina sola 30.